344 related articles for article (PubMed ID: 22381901)
1. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
2. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts.
Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK
Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573
[TBL] [Abstract][Full Text] [Related]
4. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced-MRI of tumor hypoxia.
Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
Magn Reson Med; 2012 Feb; 67(2):519-30. PubMed ID: 21661044
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging of human melanoma xenografts with necrotic regions.
Gaustad JV; Benjaminsen IC; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2007 Jul; 26(1):133-43. PubMed ID: 17659570
[TBL] [Abstract][Full Text] [Related]
7. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling.
Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
Magn Reson Imaging; 2008 Feb; 26(2):160-70. PubMed ID: 17692490
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
[TBL] [Abstract][Full Text] [Related]
9. Limitations of dynamic contrast-enhanced MRI in monitoring radiation-induced changes in the fraction of radiobiologically hypoxic cells in human melanoma xenografts.
Benjaminsen IC; Melås EA; Mathiesen BS; Rofstad EK
J Magn Reson Imaging; 2008 Nov; 28(5):1209-18. PubMed ID: 18972344
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure.
Gulliksrud K; Brurberg KG; Rofstad EK
Radiother Oncol; 2009 Apr; 91(1):107-13. PubMed ID: 18973959
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images.
Egeland TA; Simonsen TG; Gaustad JV; Gulliksrud K; Ellingsen C; Rofstad EK
Radiat Res; 2009 Sep; 172(3):339-47. PubMed ID: 19708783
[TBL] [Abstract][Full Text] [Related]
13. DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
Ellingsen C; Hompland T; Galappathi K; Mathiesen B; Rofstad EK
Radiother Oncol; 2014 Feb; 110(2):335-41. PubMed ID: 24231244
[TBL] [Abstract][Full Text] [Related]
14. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging.
Gaustad JV; Benjaminsen IC; Graff BA; Brurberg KG; Ruud EB; Rofstad EK
J Magn Reson Imaging; 2005 Jun; 21(6):792-800. PubMed ID: 15906326
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging.
Gulliksrud K; Øvrebø KM; Mathiesen B; Rofstad EK
Radiother Oncol; 2011 Mar; 98(3):360-4. PubMed ID: 21262548
[TBL] [Abstract][Full Text] [Related]
16. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI.
Egeland TA; Gaustad JV; Vestvik IK; Benjaminsen IC; Mathiesen B; Rofstad EK
Magn Reson Med; 2006 Apr; 55(4):874-82. PubMed ID: 16506163
[TBL] [Abstract][Full Text] [Related]
17. Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI.
Hompland T; Ellingsen C; Øvrebø KM; Rofstad EK
Cancer Res; 2012 Oct; 72(19):4899-908. PubMed ID: 23027087
[TBL] [Abstract][Full Text] [Related]
18. Changes in intratumor heterogeneity in blood perfusion in intradermal human melanoma xenografts during tumor growth assessed by DCE-MRI.
Graff BA; Benjaminsen IC; Melås EA; Brurberg KG; Rofstad EK
Magn Reson Imaging; 2005 Nov; 23(9):961-6. PubMed ID: 16310112
[TBL] [Abstract][Full Text] [Related]
19. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts.
Benjaminsen IC; Graff BA; Brurberg KG; Rofstad EK
Magn Reson Med; 2004 Aug; 52(2):269-76. PubMed ID: 15282808
[TBL] [Abstract][Full Text] [Related]
20. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.
Rofstad EK; Mathiesen B; Henriksen K; Kindem K; Galappathi K
Cancer Res; 2005 Mar; 65(6):2387-96. PubMed ID: 15781654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
